Trial Profile

Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Salsalate (Primary)
Indications Type 2 diabetes mellitus
Focus Pharmacodynamics; Therapeutic Use
Acronyms TINSAL-FMD; TINSAL-T2D

Most Recent Events

08 Apr 2019 Biomarkers information updated
12 Jun 2012 Substudy results assessing the effects of treatment on flow-mediated dilation presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
16 Apr 2012 Actual number of patients changed from 108 to 277 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com